CARDIAC BIOMARKERS. CASE STUDIES AND CLINICAL CORRELATIONS

1. The patient with chest pain: The troponin story
2. Troponin Basics for the clinician
3. Pathophysiology of trop I and T in myocardial ischemia/infarction
4. International Definition of MI- rationale and practice
5. Evaluation of patients presenting with chest pain- where do troponins fit in
6. Using contemporary troponin in patients with AMI
7. Using troponins to guide therapy in ACS
8. Use of cTn in patients with heart failure
9. Elevated cTn in other acute situations
10. Use of cTn for detection of more chronic disease states
11. High sensitivity assays- what are they and why do we need them
12. Use of troponin for the evaluation of patients potentially at risk for cardiovascular disease
13. Gaps in our biomarker armamentarium – what novel biomarkers might be synergistic in patients with acute disease
14. The patient with shortness of breath: the natriuretic peptide story
15. Evaluation of patients presenting with sob- where do nps fit in
16. Pathophysiology of bnp, and ntpro bnp
17. A clinicians guide to lab assays for nps
18. Using NPS in the ED- diagnosis
19. Using NPs in the ED- algorithms and risk stratification
20. Using NPs in the hospital
21. NPs at the time of discharge
22. Finger stick NP levels at home
23. Guiding therapy of heart failure with NPs
24. Caveats to NP measurement
25. Other biomarkers for heart failure
26. Biomarkers of cardiorenal disease,- Biomarkers of cardiac risk.

This book covers ACS and Heart Failure, the chapters represent the most current, up to date and knowledgeable content on the topic available. It is written by the worlds most respected leaders in biomarkers, with a majority emphasis on what clinicians need to know.
The Editors and their contributors have provided algorithms, annotated case discussions and caveats. They cover biomarkers to predict risk of heart disease, biomarkers of cardiorenal disease , and conclude with a section on new and emerging biomarkers. It be genuinely helpful and practical to those in the field, including not just people working in the field, but nurses, doctors, etc who practice medicine in the clinic, the emergency department and the hospital.

Features
• Contains clinical cases detailing the uses of biomarkers to define outcomes
• Takes a teaching file approach to establish best practice
• Presents clinical information in a practical manner and includes a wealth of algorithms and explanatory illustrations


Authors
• Alan S. Maisel is a Professor of Medicine at the University of California, San Diego (UCSD). He is the Director of the Coronary Care Unit and Heart Failure Program at the VA San Diego Healthcare System in La Jolla, California. Dr. Maisel is active on the faculty at UCSD where he has won numerous teaching awards. Dr Maisel is considered one of the world’s experts on cardiac biomarkers and has over 300 scientific publications. He has authored several ground-breaking publications that have paved the way for development of diagnostic tools for patients with congestive heart failure. In particular, he was the leading investigator on studies that brought the use of BNP into clinical practice. Dr Maisel is also a writer of medical fiction. His first novel, Bedside Manners was optioned to Warner Brothers. His second novel, Brain Chicane, is about a young and idealistic physician working at the premier multiple-organ transplant hospital in Chicago where he investigates overdose cases that are not totally kosher.
• Allan Jaffe is Professor of Medicine and Professor of Laboratory Medicine and Pathology and Chair of the Division of Core Clinical Laboratory Services at Mayo. He continues as an active clinician in the CCU. Dr. Jaffe has national and international repute for his work in cardiac biomarkers and co-ordinates the Biochemistry group of the taskforce for the Universal Definition of AMI. He is on the editor boards of most of the major cardiology journals and the most prestigious laboratory medicine one (Clinical Chemistry) as well. He has over 500 publications, mostly in the field of biomarkers and cardiac troponin.